from the free-as-a-mosquito dept.
smellsofbikes writes "GlaxoSmithKline, the world's second-largest pharmaceutical company, is putting thousands of possible malaria-treating drugs into the public domain in a move that the Wall Street Journal calls a 'Linux approach' to pharmaceutical screening. Andrew Witty, who is described as the boss of GSK, says the company thinks it is 'imperative to earn the trust of society, not just by meeting expectations but by exceeding them.' Of course, synthesis or discovery of new chemicals is cheap compared to efficacy and qualification studies, but this is a refreshing change from not handing out any information until after everything is patented."
Congratulations! You are the one-millionth user to log into our system.
If there's anything special we can do for you, anything at all, don't
hesitate to ask!